23Andme Competitors

Delisted . USA . 
Stock . 23Andme Holding Co
MEDelisted Stock  USD 0.61  0.14  18.67%   
23Andme Holding competes with IDEXX Laboratories, Twist Bioscience, Guardant Health, Agilent Technologies, and Thermo Fisher; as well as few others. The company is active under Biotechnology sector as part of Health Care industry. Analyzing 23Andme Holding competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of 23Andme Holding to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued.

23Andme Holding vs Waters Correlation

Poor diversification

The correlation between 23Andme Holding Co and WAT is 0.61 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and WAT in the same portfolio, assuming nothing else is changed.

Moving together with 23Andme Stock

  0.88TRNR Interactive StrengthPairCorr
  0.84APVO Aptevo TherapeuticsPairCorr

Moving against 23Andme Stock

  0.9CYD China Yuchai InternaPairCorr
  0.9CGECF Cogeco IncPairCorr
  0.88EMMA Emmaus Life SciencesPairCorr
  0.86SLSR Solaris ResourcesPairCorr
  0.85TOGOF TomaGoldPairCorr
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of 23Andme Holding's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.610.610.61
Details
Intrinsic
Valuation
LowRealHigh
0.580.580.67
Details

23Andme Holding Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between 23Andme Holding and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of 23Andme and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of 23Andme Holding does not affect the price movement of the other competitor.

High positive correlations

A
+ 0.88
IDXX
DHR
+ 0.82
TMO
GH
+ 0.55
TWST
TMO
+ 0.55
GH
TMO
+ 0.53
IDXX
DHR
+ 0.51
GH
  

High negative correlations

A
- 0.7
TWST
TWST
- 0.61
IDXX
TMO
- 0.09
TWST
A
- 0.06
GH
DHR
- 0.05
TWST
BIOC
- 0.0
DHR

Risk-Adjusted Indicators

There is a big difference between 23Andme Stock performing well and 23Andme Holding Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze 23Andme Holding's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

23Andme Holding Competitive Analysis

The better you understand 23Andme Holding competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, 23Andme Holding's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across 23Andme Holding's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ME IDXX TWST GH A TMO DHR ILMN WAT
 18.67 
 0.61 
23Andme
 1.97 
 629.35 
IDEXX
 3.04 
 49.11 
Twist
 2.03 
 104.85 
Guardant
 0.74 
 125.81 
Agilent
 0.98 
 504.82 
Thermo
 1.10 
 212.58 
Danaher
 2.07 
 116.81 
Illumina
 1.11 
 323.37 
Waters
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Weakest
Weakest
Solid
Soft
Weakest
Weakest
Weakest
Weakest
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Hazard
Tiny
Low
Low
Tiny
Tiny
Tiny
Low
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Fairly Valued
Fairly Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Buy
Strong Buy
Strong Buy
Buy
Strong Buy
Strong Buy
Buy
Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Hold
Strong Buy
Cautious Hold
Strong Hold
Strong Hold
Strong Hold
Hold
Strong Hold
Current Ratio
3.49
0.89
6.58
6.18
2.03
1.74
1.78
0.93
2.1
Net Asset
395.17 M
3.35 B
641.86 M
1.49 B
12.73 B
110.34 B
83.46 B
6.64 B
5.08 B
Profit Margin
-1.87
0.25
-0.2
-0.44
0.19
0.15
0.15
0.2
0.2
EBITDA
(291.87 M)
1.47 B
(52.1 M)
(390.12 M)
1.83 B
10.89 B
6.95 B
1.46 B
802.59 M
Operating Margin
-0.42
0.29
-0.32
-0.37
0.26
0.2
0.22
0.2
0.34
Current Valuation
20.23 M
50.92 B
2.91 B
14.36 B
37.15 B
218.94 B
164.08 B
18.78 B
32.54 B
Price To Book
0.62
31.3
6.59
55.67
5.28
3.55
2.86
6.56
12.38
Retained Earnings
(2.17 B)
5.33 B
(1.32 B)
(2.58 B)
1.39 B
53.1 B
46.89 B
(392 M)
9.79 B
Current Asset
212.32 M
821.63 M
N/A
219.68 M
3.63 B
1.77 B
7.84 B
2.1 B
3.21 B
Five Year Return
N/A
N/A
N/A
N/A
0.73
0.23
0.42
N/A
N/A
Beta
1.2
1.66
2.27
1.65
1.3
0.95
0.96
1.45
1.18
Number Of Employees
560
11 K
979
2 K
18.1 K
125 K
60 K
8.97 K
7.9 K
Shares Outstanding
19.72 M
79.85 M
61.31 M
129.87 M
282.84 M
375.71 M
706.9 M
152.9 M
98.09 M
Cash Flow From Operations
(164.32 M)
1.18 B
(47.63 M)
(239.86 M)
1.56 B
7.82 B
6.42 B
1.08 B
652.55 M
Annual Yield
N/A
N/A
N/A
N/A
0.0081
0.0034
0.006
N/A
N/A
Total Debt
76.52 M
847.84 M
137.32 M
1.34 B
3.35 B
39.38 B
18.42 B
2.96 B
2.52 B
Return On Equity
-1.94
0.66
-0.17
-45.84
0.21
0.13
0.0705
0.33
0.29
Z Score
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.33
0.26
-0.13
-0.2
0.0849
0.0504
0.0364
0.0839
0.12
Number Of Shares Shorted
1.79 M
1.81 M
12.17 M
9.48 M
4.28 M
4.77 M
7.14 M
8.3 M
2.25 M
Book Value Per Share
2.35
20.09
7.44
-2.84
23.82
142.06
74.32
17.8
43.01
Current Liabilities
372.61 M
856.76 M
N/A
24.24 M
945 M
1.1 B
6.17 B
610.49 M
564.08 M
Total Asset
395.17 M
3.35 B
641.86 M
1.49 B
12.73 B
110.34 B
83.46 B
6.64 B
5.08 B
Debt To Equity
0.099
3.28
0.12
4.32
0.52
0.67
0.43
0.38
4.0
Short Ratio
3.82
3.9
9.52
4.94
2.19
1.89
1.93
4.32
4.72
Target Price
2.08
750.23
49.89
125.24
169.67
666.46
264.86
135.84
402.71
Last Dividend Paid
N/A
N/A
N/A
N/A
0.99
1.72
1.28
N/A
N/A
Shares Owned By Institutions
26.07
99.31
98.46
99.09
91.56
92.43
83.57
99.81
60.22
Market Capitalization
13.34 M
50.35 B
3.01 B
13.62 B
35.67 B
189.66 B
150.27 B
17.86 B
31.72 B
Price To Earning
-3.48
61.31
N/A
-12.01
37.55
30.99
29.97
49.12
40.43
Price To Earnings To Growth
N/A
3.74
-0.04
-0.66
1.7
1.86
2.0
0.62
3.58
Price To Sales
0.0639
11.7
7.69
15.09
5.13
4.26
6.12
4.11
10.02
Net Income
(666.7 M)
1.06 B
(77.67 M)
(436.37 M)
434 M
6.72 B
3.61 B
850 M
642.63 M
Earnings Per Share
-17.39
13.09
-1.27
-3.22
4.57
17.72
5.04
5.46
10.77
Shares Owned By Insiders
17.26
0.69
1.54
4.09
0.18
0.15
11.05
0.19
0.1
Revenue
219.64 M
4.3 B
376.57 M
739.02 M
6.95 B
44.56 B
24.57 B
4.34 B
3.17 B
Working Capital
127.98 M
331.98 M
241.56 M
829.53 M
2.25 B
8.8 B
2.7 B
1.7 B
879.35 M
Cash And Equivalents
410.89 M
114.36 M
504.97 M
853.69 M
1.79 B
9.85 B
4.62 B
1.42 B
587.83 M
Cash Per Share
0.9
1.37
8.93
8.35
3.57
7.44
7.07
6.62
7.01
Gross Profit
110.72 M
2.66 B
202.13 M
575.46 M
3.64 B
18.57 B
14.52 B
2.96 B
1.88 B
Day Typical Price
0.77
623.81
48.97
104.67
126.2
509.81
214.04
116.38
321.11
Accumulation Distribution
0.45
0.0472
0.0508
0.0345
0.0215
0.0309
0.0364
0.0209
0.0361
Market Facilitation Index
0.5
30.01
2.55
3.67
2.75
16.1
7.96
2.45
11.78
Daily Balance Of Power
(0.28)
0.4049
0.5686
0.5695
0.3382
(0.31)
(0.30)
0.9673
0.3005
Period Momentum Indicator
(0.14)
12.15
1.45
2.09
0.93
(5.00)
(2.36)
2.37
3.54
Rate Of Daily Change
0.81
1.02
1.03
1.02
1.01
0.99
0.99
1.02
1.01
Day Median Price
0.85
621.04
48.9
104.59
126.4
512.3
214.77
116.17
319.98
Price Action Indicator
(0.31)
14.38
0.94
1.31
(0.12)
(9.98)
(3.37)
1.83
5.16
Coefficient Of Variation
(685.90)
(1,080)
519.74
1975.67
(780.06)
(791.03)
6439.15
(7,688)
(1,096)
Mean Deviation
5.98
1.27
3.11
2.02
1.27
1.15
1.14
1.85
1.23
Jensen Alpha
(1.66)
(0.24)
0.6085
0.069
(0.30)
(0.26)
(0.04)
(0.05)
(0.28)
Total Risk Alpha
(2.55)
(0.31)
0.4698
(0.08)
(0.35)
(0.31)
(0.1)
(0.22)
(0.38)
Sortino Ratio
N/A
N/A
0.2138
0.026
N/A
N/A
(0.03)
N/A
N/A
Downside Variance
N/A
N/A
11.07
7.82
N/A
N/A
2.48
N/A
N/A
Standard Deviation
11.53
1.79
4.06
2.82
1.66
1.49
1.48
2.46
2.24
Kurtosis
13.26
1.83
1.23
2.31
0.2185
0.0263
0.8322
3.6
21.5
Potential Upside
9.8
3.61
7.7
4.16
2.9
2.43
2.3
3.85
3.25
Treynor Ratio
3.17
(0.17)
0.2838
0.1249
(0.17)
(0.19)
0.0144
(0.20)
(0.19)
Maximum Drawdown
72.68
10.16
17.96
17.61
7.85
7.2
8.05
15.59
18.0
Variance
132.89
3.21
16.5
7.94
2.75
2.22
2.2
6.07
5.01
Market Risk Adjusted Performance
3.18
(0.16)
0.2938
0.1349
(0.16)
(0.18)
0.0244
(0.19)
(0.18)
Risk Adjusted Performance
(0.11)
(0.07)
0.1633
0.048
(0.1)
(0.1)
0.0171
(0)
(0.07)
Skewness
(1.27)
0.1439
0.4158
0.2324
0.3886
0.0492
(0.34)
(0.83)
(3.35)
Semi Deviation
N/A
N/A
2.91
2.64
N/A
N/A
1.49
N/A
N/A
Information Ratio
(0.15)
(0.13)
0.1752
0.0258
(0.17)
(0.17)
(0.03)
(0.04)
(0.12)
Value At Risk
(18.46)
(3.18)
(4.95)
(4.48)
(2.73)
(2.55)
(2.29)
(3.26)
(2.08)
Expected Short fall
N/A
N/A
(3.74)
(2.10)
N/A
N/A
(1.13)
N/A
N/A
Downside Deviation
N/A
N/A
3.33
2.8
N/A
N/A
1.58
N/A
N/A
Semi Variance
N/A
N/A
8.45
6.96
N/A
N/A
2.23
N/A
N/A

23Andme Holding Competition Performance Charts

Five steps to successful analysis of 23Andme Holding Competition

23Andme Holding's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by 23Andme Holding in relation to its competition. 23Andme Holding's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of 23Andme Holding in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact 23Andme Holding's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to 23Andme Holding, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your 23Andme Holding position

In addition to having 23Andme Holding in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Aggressive Defence Thematic Idea Now

Aggressive Defence
Aggressive Defence Theme
Macroaxis small cap, aggressive-outlook picks designed for investors that are willing to accept higher levels of risk to hedge exposure to above-average market volatility. The Aggressive Defence theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aggressive Defence Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Consideration for investing in 23Andme Stock

If you are still planning to invest in 23Andme Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the 23Andme Holding's history and understand the potential risks before investing.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Global Correlations
Find global opportunities by holding instruments from different markets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY